JERUSALEM/TEL AVIV, Israel – On his first full day of his economic development mission to Israel, Governor Phil Murphy and the New Jersey delegation made stops at the Israel Innovation Authority and Teva Pharmaceuticals.
Below are photos and press release links from the day’s events:
New Jersey & Israel Sign Agreement to Strengthen Economic Ties
The New Jersey Economic Development Authority (EDA) and the Israel Innovation Authority (IIA) today announced the signing of a Memorandum of Understanding (MOU) to strengthen economic ties and enhance bi-lateral partnerships among innovators in the Garden State and the State of Israel.
The MOU outlines an agreement to further develop and strengthen economic, technological and commercial cooperation between the State of Israel and the State of New Jersey. It will help facilitate the identification of opportunities for growth in the innovation economy and foster a greater partnership between New Jersey and Israel. EDA Chief Executive Officer Tim Sullivan and IIA Chairman Amiram Appelbaum, who also serves as the Chief Scientist for the Israeli Ministry of Economy and Industry, signed the MOU in Jerusalem in the presence of Governor Phil Murphy and Ambassador Dani Dayan, Israel Consul General in New York. Click here for a copy of the full press release.
Governor Murphy Gives Official Welcome to Teva Pharmaceuticals to New Jersey
Governor Murphy visited Teva Pharmaceuticals today, where he presented CEO Kare Schultz with a Proclamation praising Teva for their decision to grow nearly 850 new jobs in New Jersey in their new headquarters in Parsippany. Following his meeting with Schultz, the Governor met with a roundtable of life sciences companies, where he made a presentation on the benefits of expanding their business in New Jersey. Click here for a copy of the full press release.